64 results
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
14 Aug 18
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
4:22pm
of these businesses have been classified as assets and liabilities held for sale on the balance sheet. All prior period information has been recast … and liabilities of these businesses have been classified as assets and liabilities held for sale on the balance sheet. All prior period information has
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
15 Nov 18
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018
4:02pm
and liabilities of these businesses have been classified as assets and liabilities held for sale on the balance sheet. All prior period information has been recast … have been classified as assets and liabilities held for sale on the balance sheet. All prior period information has been recast to conform
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
8 Jun 20
Regulation FD Disclosure
5:04pm
Analysis “Minor” includes improvements classified as between major and minor, as well as mixed. | © 2020 Soleno Therapeutics Caregiver interviews
8-K
EX-99.1
4jl fw75g3
16 May 18
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
6:08am
S-1/A
c83b49f e0ri6
1 Jul 14
IPO registration (amended)
12:00am
8-K
EX-99.1
wqcrfxy whmui
18 Mar 19
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
4:37pm
10-K
190gfwxik4vro8 m4lc3
13 Mar 15
Annual report
12:00am